Cytomegalovirus infection among patients with cancer receiving immune checkpoint inhibitors.

Autor: Panneerselvam K; Department of Internal Medicine, Baylor College of Medicine, Houston, TX (Kavea Panneerselvam, David Szafron)., Szafron D; Department of Internal Medicine, Baylor College of Medicine, Houston, TX (Kavea Panneerselvam, David Szafron)., Amin RN; Department of Internal Medicine, The University of Texas Health Science Center at Houston, Houston, TX (Rajan N. Amin)., Wei D; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX (Dongguang Wei, Dongfeng Tan)., Tan D; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX (Dongguang Wei, Dongfeng Tan)., Altan M; Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX (Mehmet Altan)., Okhuysen PC; Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX (Pablo C. Okhuysen)., Shatila M; Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, TX (Malek Shatila, Gottumukkala Subba Raju, Anusha S. Thomas, Yinghong Wang), USA., Raju GS; Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, TX (Malek Shatila, Gottumukkala Subba Raju, Anusha S. Thomas, Yinghong Wang), USA., Thomas AS; Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, TX (Malek Shatila, Gottumukkala Subba Raju, Anusha S. Thomas, Yinghong Wang), USA., Wang Y; Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, TX (Malek Shatila, Gottumukkala Subba Raju, Anusha S. Thomas, Yinghong Wang), USA.

Publikováno v: Annals of gastroenterology [Ann Gastroenterol] 2022 Sep-Oct; Vol. 35 (5), pp. 522-531. Date of Electronic Publication: 2022 Jul 15.